These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25546798)

  • 1. Optimizing immunoglobulin G therapy in chronic autoimmune neuropathies.
    Berger M
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):144-5. PubMed ID: 25546798
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose and outcomes in primary immunodeficiency disorders.
    Bonagura VR
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):7-9. PubMed ID: 25546743
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcutaneous IgG in neurologic diseases.
    Berger M
    Immunotherapy; 2014; 6(1):71-83. PubMed ID: 24341886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 7th International Immunoglobulin Conference: Neurology.
    Nobile-Orazio E; Lewis RA
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):22-4. PubMed ID: 25546749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein-glycan interactions as targets of intravenous/subcutaneous immunoglobulin (IVIg/SCIg) preparations.
    von Gunten S
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):151-2. PubMed ID: 25546801
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravenous immune globulin in autoimmune and inflammatory diseases.
    Gelfand EW
    N Engl J Med; 2012 Nov; 367(21):2015-25. PubMed ID: 23171098
    [No Abstract]   [Full Text] [Related]  

  • 7. Will sialylation change intravenous immunoglobulin therapy in the future?
    Käsermann F; Campbell IK
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):100-2. PubMed ID: 25546779
    [No Abstract]   [Full Text] [Related]  

  • 8. Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.
    Czernik A
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):118-9. PubMed ID: 25546786
    [No Abstract]   [Full Text] [Related]  

  • 9. 7(th) International Immunoglobulin Conference: Poster presentations.
    Warnatz K; Ballow M; Stangel M; Bril V
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):139-40. PubMed ID: 25546796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Intravenous immunoglobulin therapy].
    Mouthon L
    Rev Prat; 2005 May; 55(10):1049-56. PubMed ID: 16097244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcutaneous Immunoglobulins: A Promising Alternative for Immunomodulation?
    Sanchez-Ramon S; Corbi AL; Fidalgo AG; Dominguez-Soto A
    Curr Pharm Des; 2016; 22(41):6300-6305. PubMed ID: 27587200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of intravenous immunoglobulin and plasma exchange in neurological disease.
    Linker RA; Gold R
    Curr Opin Neurol; 2008 Jun; 21(3):358-65. PubMed ID: 18451723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of experimental autoimmune myasthenia gravis by intravenous immunoglobulin and isolation of a disease-specific IgG fraction.
    Fuchs S; Feferman T; Zhu KY; Meidler R; Margalit R; Wang N; Laub O; Souroujon MC
    Ann N Y Acad Sci; 2007 Sep; 1110():550-8. PubMed ID: 17911471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical uses of intravenous immunoglobulin.
    Jolles S; Sewell WA; Misbah SA
    Clin Exp Immunol; 2005 Oct; 142(1):1-11. PubMed ID: 16178850
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of HIV infection by passive immunization with HIVIG or CD4-IgG.
    Eichberg JW; Murthy KK; Ward RH; Prince AM
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1515. PubMed ID: 1466993
    [No Abstract]   [Full Text] [Related]  

  • 16. Autoimmune GFAP-Associated Meningoencephalomyelitis: A Report of a Pediatric Patient.
    Trau SP; Gallentine WB
    Pediatr Neurol; 2018 May; 82():50. PubMed ID: 29622490
    [No Abstract]   [Full Text] [Related]  

  • 17. Introduction.
    Gelfand EW
    Int Immunopharmacol; 2006 Apr; 6(4):515-6. PubMed ID: 16504912
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunotherapy for autoimmune autonomic ganglionopathy.
    Iodice V; Kimpinski K; Vernino S; Sandroni P; Low PA
    Auton Neurosci; 2009 Mar; 146(1-2):22-5. PubMed ID: 19056323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.
    Christiansen OB
    Clin Exp Immunol; 2014 Dec; 178 Suppl 1(Suppl 1):120-2. PubMed ID: 25546787
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin.
    McGuire WA; Yang HH; Bruno E; Brandt J; Briddell R; Coates TD; Hoffman R
    N Engl J Med; 1987 Oct; 317(16):1004-8. PubMed ID: 3116428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.